Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation.

about

Molecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantation.

P2860

Q45351795-D17619A1-9206-4735-954A-9DE4BD0C9788

P2860

Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation.

Item

http://www.wikidata.org/entity/Q45764128

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Epstein - Barr virus - associa ...... tic Stem Cell Transplantation.

@en

Epstein - Barr virus - associa ...... tic Stem Cell Transplantation.

@nl

type

Item

label

Epstein - Barr virus - associa ...... tic Stem Cell Transplantation.

@en

Epstein - Barr virus - associa ...... tic Stem Cell Transplantation.

@nl

prefLabel

Epstein - Barr virus - associa ...... tic Stem Cell Transplantation.

@en

Epstein - Barr virus - associa ...... tic Stem Cell Transplantation.

@nl

P1476

Epstein - Barr virus - associa ...... tic Stem Cell Transplantation.

@en

P2093

Qi-fa Liu

http://www.w3.org/2001/XMLSchema#string

Xiu-li Wu

http://www.w3.org/2001/XMLSchema#string

P2860

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome.

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

Overview of Epstein-Barr virus-associated diseases in Japan.

How I treat EBV lymphoproliferation.

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.

Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges.

P2888

1756-8722-5-s1-a8

P304

A8-A8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-8722-5-S1-A8

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023249340

http://www.w3.org/2001/XMLSchema#string

P932

3337262

http://www.w3.org/2001/XMLSchema#string

Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation.

about

P2860

P2860

Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P932